Mass General Study Suggests Benefit from Broad NSCLC Genotyping in Routine Clinical Practice
December 07, 2011
Mass General Study Suggests Benefit from Broad NSCLC Genotyping in Routine Clinical Practice
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - Caris Life Sciences Presents Biomarker Findings Culled from Growing Database of Target Now Patients
September 14, 2011 / Pharmacogenomics Reporter - Genotox Labs Announced as First Customer for Translational Software’s PGx Interpretation, Integration Service
February 13, 2013 / Pharmacogenomics Reporter - Case Study Suggests FISH Test May Miss Some Patients Who Could Benefit from Crizotinib
September 12, 2012 / Pharmacogenomics Reporter - OICR Reports Pilot Data from Clinical Sequencing Study; Switching from PacBio to MiSeq in Second Stage
September 12, 2012 / Clinical Sequencing News